Treatment of pluripotent cells
The present invention is provides a method for treating human pluripotent cells. In particular, the methods of the invention are directed to the treatment of human pluripotent cells, whereby the human pluripotent cells can be efficiently expanded in culture and differentiated by treating the pluripotent cells with an inhibitor of glycogen synthase kinase 3β (GSK-3B) enzyme activity.
Janssen Biotech, Inc.
C C C C C C C A C C C C C
C12N C12N C12N C12N C12N C12N C12N A61K C12N C12N C12N C12N C12N
additional additional additional additional additional inventional additional additional additional inventional additional additional additional
Janet Jiajian
Davis Liu